| Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017 C Hiemke, N Bergemann, HW Clement, A Conca, J Deckert, K Domschke, ... Pharmacopsychiatry 51 (01/02), 9-62, 2018 | 1492 | 2018 |
| AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011 C Hiemke, P Baumann, N Bergemann, A Conca, O Dietmaier, K Egberts, ... Pharmacopsychiatry 21 (06), 195-235, 2011 | 1136 | 2011 |
| The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry P Baumann, C Hiemke, S Ulrich, G Eckermann, I Gaertner, M Gerlach, ... Pharmacopsychiatry 37 (06), 243-265, 2004 | 618 | 2004 |
| Calcium channels and calcium channel drugs: recent biochemical and biophysical findings H Glossmann, DR Ferry, A Goll, J Striessnig, G Zernig Arzneimittelforschung 35 (12A), 1917-1935, 1985 | 217 | 1985 |
| Widening potential for Ca2+ antagonists: non-L-type Ca2+ channel interaction G Zernig Trends in Pharmacological Sciences 11 (1), 38-44, 1990 | 157 | 1990 |
| Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests G Zernig, SH Ahmed, RN Cardinal, D Morgan, E Acquas, RW Foltin, ... Pharmacology 80 (2-3), 65-119, 2007 | 140 | 2007 |
| Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations W Aichhorn, J Marksteiner, T Walch, G Zernig, A Saria, G Kemmler International clinical psychopharmacology 21 (2), 81-85, 2006 | 139 | 2006 |
| TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians G Schoretsanitis, M Paulzen, S Unterecker, M Schwarz, A Conca, ... The world journal of biological psychiatry 19 (3), 162-174, 2018 | 132 | 2018 |
| Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam R Rygula, N Abumaria, U Havemann-Reinecke, E Rüther, C Hiemke, ... Behavioural pharmacology 19 (3), 183-196, 2008 | 129 | 2008 |
| Blood levels to optimize antipsychotic treatment in clinical practice: a joint consensus statement of the American Society of Clinical Psychopharmacology and the Therapeutic … G Schoretsanitis, JM Kane, CU Correll, SR Marder, L Citrome, ... The journal of clinical psychiatry 81 (3), 3649, 2020 | 128 | 2020 |
| Reversal of cocaine‐conditioned place preference and mesocorticolimbic Zif268 expression by social interaction in rats M Fritz, R El Rawas, A Salti, S Klement, MT Bardo, G Kemmler, G Dechant, ... Addiction biology 16 (2), 273-284, 2011 | 121 | 2011 |
| Influence of age and gender on risperidone plasma concentrations W Aichhorn, U Weiss, J Marksteiner, G Kemmler, T Walch, G Zernig, ... Journal of psychopharmacology 19 (4), 395-401, 2005 | 118 | 2005 |
| Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure. EA Walker, G Zernig, JH Woods The Journal of pharmacology and experimental therapeutics 273 (3), 1345-1352, 1995 | 105 | 1995 |
| Reinforcing effects of MDMA (‘ecstasy’) in drug-naive and cocaine-trained rats E Ratzenboeck, A Saria, N Kriechbaum, G Zernig Pharmacology 62 (3), 138-144, 2001 | 102 | 2001 |
| Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys. ER Butelman, G Winger, G Zernig, JH Woods The Journal of pharmacology and experimental therapeutics 272 (2), 845-853, 1995 | 100 | 1995 |
| Conditioned place preference for social interaction in rats: contribution of sensory components K Kummer, S Klement, V Eggart, MJ Mayr, A Saria, G Zernig Frontiers in behavioral neuroscience 5, 80, 2011 | 89 | 2011 |
| MDMA (‘ecstasy’) enhances basal acetylcholine release in brain slices of the rat striatum HS Fischer, G Zernig, DS Schatz, C Humpel, A Saria European Journal of Neuroscience 12 (4), 1385-1390, 2000 | 88 | 2000 |
| Activation of muscarinic and nicotinic acetylcholine receptors in the nucleus accumbens core is necessary for the acquisition of drug reinforcement JA Crespo, K Sturm, A Saria, G Zernig Journal of Neuroscience 26 (22), 6004-6010, 2006 | 87 | 2006 |
| Nicotine and heroin augment cocaine-induced dopamine overflow in nucleus accumbens G Zernig, IA O'Laughlin, HC Fibiger European journal of pharmacology 337 (1), 1-10, 1997 | 86 | 1997 |
| Human red‐blood‐cell Ca2+‐antagonist binding sites: Evidence for an unusual receptor coupled to the nucleoside transporter J Striessnig, G Zernig, H Glossmann European journal of biochemistry 150 (1), 67-77, 1985 | 86 | 1985 |
